about
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cellsA systematic review of drug induced ocular reactions in diabetes.The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model.A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal featuresIrreversible visual loss secondary to excessive topical steroid use in eczemaInflammatory response in the anterior chamber after implantation of an angle-supported lens in phakic myopic eyes.Under pressure: an ocular complication of oral corticosteroid therapyTherapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in MiceDendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and ImmunopathologyLong-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.Bilateral cataracts and glaucoma induced by long term use of steroid eye dropsEfficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components.Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonistPharmacokinetic Studies of Sustained-Release Depot of Dexamethasone in Beagle DogsCXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence.A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation.Family-based whole exome sequencing of atopic dermatitis complicated with cataracts.Loss of αB-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart.Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.Emerging treatment options for the management of pemphigus vulgaris.
P2860
Q24644700-65C0C76B-BEF3-4C39-92C7-99BF1C808DEAQ33828301-4F773E69-B370-405D-82D5-01759DB690EBQ34160692-E4A480E6-DF00-4BD0-8426-C68824EC9FF7Q34708308-8495EF5F-6D9F-4DF0-9751-DE77B180BC34Q35182238-47736084-DEFE-4DC3-BA1F-F61275C5DA29Q35196174-AE48D5F0-1124-4963-A822-14320F102633Q35980538-59D7E825-59C6-435C-A8FC-038E7457FAB0Q36124928-1D27C1EF-DA13-4E45-A574-8F2F6240C0F5Q36227278-874C5602-523D-46D1-B5C5-8BC2072B9D3AQ36533886-2CF614E3-B3C7-4F0A-965B-DF50CD977C81Q36890415-8F1DE79B-2C5F-42E6-A43B-AE52C7AFFFD4Q36906812-67E0720F-3F40-4FEB-9B19-833A5CF0FFD5Q37059858-F8DE1829-AEBD-4416-BBCD-25ECE77525C1Q37295510-B4C50E47-73AC-4A4A-94BF-642E0E265A14Q37409001-8EDF743A-A3A8-4B10-B9F6-8292A5A00B19Q37623874-A47B5FB6-1498-4278-91FE-A75C0551DB94Q38230010-4F8C6AC2-8898-4288-A35B-4241689DE14BQ41605722-36A4EE4D-EB5B-478D-8FF5-95818CAD7A43Q41708742-4889E835-6867-4B98-9EFB-46C4BE8C91D7Q47377350-24329121-958E-4642-A496-18A489AE45C7Q50147046-B85CFD0F-B8EF-4FAB-9FF0-83EB39391B4EQ55433740-364DB2B0-B368-4C7F-B2E3-757D942B9A89
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Ocular effects of topical and systemic steroids.
@ast
Ocular effects of topical and systemic steroids.
@en
type
label
Ocular effects of topical and systemic steroids.
@ast
Ocular effects of topical and systemic steroids.
@en
prefLabel
Ocular effects of topical and systemic steroids.
@ast
Ocular effects of topical and systemic steroids.
@en
P1433
P1476
Ocular effects of topical and systemic steroids
@en
P2093
P304
P356
10.1016/S0733-8635(18)30318-8
P577
1992-07-01T00:00:00Z